World Drug Safety Congress Americas 2018 Prospectus

information we require

please check before submitting

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Dear future World Drug Safety Congress Americas 2018 delegate,


Drug Safety remains a key topic as the regulatory landscape evolves to meet the demands of scientific innovation. In our ninth year, we will be covering the latest technological developments in drug safety including integration, data source, signal detection, safety analytics and regulation.


Since its launch in 2008, this conference has stood out as a unique forum for the industry. Not only are we discussing the latest advances, practical sessions will provide you the tools to tackle day-to-day challenges. Topics under discussion in 2018 include the use of social media to support risk management practices, applying fresh thinking to signal management challenges, outsourcing vs. in-house clinical data management and achieving collaboration between pharmacovigilance and technology.

2018 is set to be the best year yet, with even more pharma representation than ever before. Companies who joined us last year included  AbbVie, Alexion Pharmaceuticals, Amgen, AstraZeneca, Baxalta, Bristol Myers Squibb, Genentech, Genzyme, GlaxoSmithKline, Horizon Pharma, Merck, Novartis, Pfizer, Sanofi, and Takeda Pharmaceuticals . If you want to be among their company, and many more, act quickly. 


World Drug Safety Congress Americas is the meeting place of global pioneers who are shaping the pharmacovigilance industry.


We hope you join our movement.